Breaking Down Barriers to Biosimilar Access
November 26, 2025
With new approvals for its denosumab biosimilars, Biocon Biologics is working to close gaps in access across Europe...
6 min read
False
Advertisement
Industry News
This Week’s Biopharma News: New Restrictions on Sarepta Gene Therapy
November 18, 2025
Our latest news roundup reports on the FDA’s new “plausible mechanism” pathway, Novartis’s phase III malaria trial, a new gene therapy in Europe, and more.
4 min read
This Week’s Biopharma News: Clinical Hold for Heart Disease Gene Therapy
November 12, 2025
Our latest news roundup reports on Novartis’ new radioligand facility in California, new tech for boosting AAV yields, and MeiraGTx’s deal with Eli Lilly
4 min read
Promising Early Results in Solid Tumor Trial
November 11, 2025
Lyell Immunopharma acquires rights to CAR T cell therapy for solid tumors
2 min read
Malaria Vaccine Development: Oxford and ReciBioPharm Extend Manufacturing Deal
November 10, 2025
Expanded collaboration between Recipharm Advanced Bio and the UK’s University of Oxford targets vaccine candidates for malaria
4 min read
Integrity and Industry: Balancing Purpose and Profit
November 6, 2025
An invitation to our readers to feed back on our content
1 min read
George Tidmarsh: FDA Resignation and Lawsuit
November 5, 2025
Tidmarsh reportedly resigns from FDA and Aurinia Pharmaceuticals files lawsuit
2 min read
Securing Europe’s Antibiotic Supply: A More Functional Future
October 31, 2025
The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.
3 min read
Texas Takes on Tylenol
October 31, 2025
Texas Attorney General is suing Tylenol manufacturers, alleging misleading safety concerns and links with autism.
2 min read
Summarizing the Big Events in the Small Molecules Field
October 30, 2025
October 2025 highlights in the small molecules sector include developments in dermatitis treatment, improvements in epilepsy symptoms, and the effects of amoxicillin availability.
4 min read
